Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vivani Medical, Inc.VANI · Entity 6636 | Chief Operations Officer | July 28, 2026 | July 31, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vivani Medical, Inc.
Report date July 28, 2026 · Filed July 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.31 · Expires 2036-07-27 | Direct | 160,000 |
Reported balance
After 2026-07-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-28 · Grant · Acquired 160,000 · Balance 160,000 F1: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. |
| RSUsSEC Table II · derivative / convertible security | Direct | 80,000 |
Reported balance
After 2026-07-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-28 · Grant · Acquired 80,000 · Balance 80,000 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock. F3: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.
F3: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2026 Filed Jul 31, 2026 00:25 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRSUs · Derivative | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-26-001283 · form4.xml · derivative · entry 2 Le Truc · CIK 0001940176 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock. F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. Read SEC document |
| July 28, 2026 Filed Jul 31, 2026 00:25 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 160,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001753926-26-001283 · form4.xml · derivative · entry 1 Le Truc · CIK 0001940176 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2036-07-27 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| May 12, 2025 Filed May 15, 2025 00:28 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRSUs · Derivative | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-25-000826 · form4.xml · derivative · entry 2 Le Truc · CIK 0001940176 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock. F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. Read SEC document |
| May 12, 2025 Filed May 15, 2025 00:28 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 160,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001753926-25-000826 · form4.xml · derivative · entry 1 Le Truc · CIK 0001940176 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2035-05-11 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| May 10, 2024 Filed May 14, 2024 22:54 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRestricted Stock Units · Derivative | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-24-000968 · ownership.xml · derivative · entry 2 Le Truc · CIK 0001940176 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock. F3 · derivative.exercise_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. F3 · derivative.expiration_date: The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire. Read SEC document |
| May 10, 2024 Filed May 14, 2024 22:54 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 160,000 | $0.00 Strike: $1.81 | $0.00 |
DisclosureSEC source: 0001753926-24-000968 · ownership.xml · derivative · entry 1 Le Truc · CIK 0001940176 · Chief Operations Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2034-05-09 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. F1 · derivative.expiration_date: The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 02:35 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantRSUs · Derivative | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-23-000265 · ownership.xml · derivative · entry 1 Le Truc · CIK 0001940176 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2027-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Vivani common stock. F2 · derivative.exercise_date: The performance based RSUs vest one third when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire. Read SEC document |
| January 19, 2023 Filed Jan 24, 2023 02:06 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 160,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-23-000074 · ownership.xml · derivative · entry 1 Le Truc · CIK 0001940176 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2033-01-19 F1 · derivative.exercise_date: The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:39 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock Option · Derivative | 150,933 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001192 · ownership.xml · derivative · entry 2 Le Truc · CIK 0001940176 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,933 Underlying: Common Stock · 150,933 shares Expires 2031-03-07 F1 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. F3 · shares: The option vests 1/48 per month over the four years after the date of grant commencing on March 7, 2021, and the balance thereafter vests in full on the fifth anniversary of the date of grant. F3 · balance_after: The option vests 1/48 per month over the four years after the date of grant commencing on March 7, 2021, and the balance thereafter vests in full on the fifth anniversary of the date of grant. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 22:39 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock Option · Derivative | 603,732 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001192 · ownership.xml · derivative · entry 1 Le Truc · CIK 0001940176 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,732 Underlying: Common Stock · 603,732 shares Expires 2030-07-30 F1 · kind: Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. F2 · shares: The option vested as to 301,866 shares on February 28, 2021 and 150,933 shares on July 16, 2021 and after July 16, 2021 the balance of the shares vested and will vest at the rate of 4312.367 shares per month for 35 months. F2 · balance_after: The option vested as to 301,866 shares on February 28, 2021 and 150,933 shares on July 16, 2021 and after July 16, 2021 the balance of the shares vested and will vest at the rate of 4312.367 shares per month for 35 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.